京都府立医科大学神経内科は、神経内科、老年内科、脳卒中診療科領域の疾患の診療・教育・研究に全力で取り組んでいます。

神経内科教室について

業績一覧へ

【2018年】

[Ⅰ] 著 書

1. 塩貝敏之.アルツハイマー病.イヤーノート・アトラス 第7版.東京:メディックメディア.pp.J26,2018.
2. 塩貝敏之.慢性硬膜下血腫.イヤーノート・アトラス 第7版.東京:メディックメディア.pp.J62,2018.
3. 徳田隆彦,笠井高士.神経難病へのエキスパート・アプローチ「第IV章-1.バイオマーカーの開発」.水澤英洋編.神経変性疾患ハンドブック 南江堂,東京:pp.336-343.2018.5.25 発行.
4. 徳田隆彦.第2編 診断から予防への . 取り組み.第1章 診断法の開発.3節 血液検査によるアルツハイマー病診断法の開発.新井平伊編集,「アルツハイマー病発 症メカニズムと新規診断法・創薬・治療開発」.株式会社エヌ・ティー・エス,東京: pp.184-190.2018 年8月 27 日発刊
5. 徳田隆彦.脳脊髄液異常症.南学正臣総編集,田中章景編集「,内科学書 改訂第9版」 第6巻「神経疾患」.中山書店,東京.2018 年(in press).
6. Tokuda T, Ishii R, Tatebe H, Kasai T, El-Agnaf OMA. Alpha-Synuclein in Cere- brospinal Fluid. Kenji Kosaka (Eds). Dementia with Lewy Bodies. Springer Ja- pan, Tokyo: 2018 (in press).
7. Washio M and Kobashi G (Eds). 2018. Kuriyama N. Chapter 6; Descriptive and analytic epidemiology of idiopathic normal pressure hydrocephalus (iNPH) in Japan. Current Topics in Environmental Health and Preventive Medicine, Epide- miological Studies of Specified Rare and Intractable Disease, Springer, Germany. pp.83-102(分担執筆)ISBN 978-981-13-1095-9.
8. 近藤正樹.行為・動作障害のみかたの変遷.行為と動作の障害.東京:新興医学出版. pp.3-20,2018.
9. 今井啓輔,濱中正嗣,山﨑英一.Trevo XP. III AIS の血管内治療はここまで進んだ. C.機器をどう使いこなすか?.脳血管内治療の進歩—プラッシュアップセミナー 2017— アクセスのすべて~脳血管内治療成功の鍵~.坂井信幸ら編集.診断と治療 社,pp.211-215,2018.
10. 松尾雄一郎.05 ギラン・バレー症候群.花山耕三 編.臨床につながる神経・筋疾患. 東京:医歯薬出版.pp.46-54,2018.
11. 松尾雄一郎.06 シャルコー・マリー・トゥース病.花山耕三 編.臨床につながる神経・筋疾患.東京:医歯薬出版.pp.56-61,2018.
12. 松尾雄一郎.09 ポストポリオ症候群.花山耕三 編.臨床につながる神経・筋疾患.東京:医歯薬出版.pp.78-85,2018.
13. 濱中正嗣,今井啓輔.治療上知っておくべき血管病理学.脳血管内治療学.大阪:株式会社メディカ出版.pp.268-272,2018.
14. Yamaguchi M (Editor), Azuma Y, Mizuta I, Tokuda T, Mizuno T. Amyotrophic Lateral Sclerosis Model. In Drosophila Models for Human Diseases. Adv Exp Med Biol. 1076: pp.79-95, 2018.
15. 能登祐一,辻有希子.絞扼性末梢神経障害(下肢).神経筋超音波研究会 編.神経筋疾患の超音波検査実践マニュアル.東京:南江堂.pp.85-92,2018.
16. Azuma Y, Mizuta I, Tokuda T, and Mizuno T. Amyotrophic Lateral Sclerosis model. Yamaguchi M, Editor. Drosophila models for human disease. Singapore:Springer. pp.79-96, 2018.
17. 大道卓摩,徳田隆彦.II.パーキンソン病の診断、鑑別.2.診断に役立つバイオマーカーはありますか?鈴木則宏監修,服部信孝・下 泰司・波田野琢編.神経内 科 Clinical Questions & Pearls 「パーキンソン病」.中外医学社,東京.2018(in press).
18. 大道卓摩,徳田隆彦.各論 B 診断 6.バイオマーカー 「バイオマーカーの現状 と将来有望なマーカーについて」.山本光利編集,「パーキンソン病の 200 年:1917- 2017」.中外医学社,東京.2018 年(in press).
19. 蒔田直輝,佐藤祥一郎,有水琢朗,藤田恭平,黒嵜健一,猪原匡史,豊田一則.成人 先天性心疾患を有する虚血性脳卒中の特徴.小児・若年性脳血管障害の現状と未来. The 36th Meeting of The Mt.Fuji Workshop on CVD.Vol.36.株式会社にゅーろ ん社.pp.75-79,2018.
20. ダニエル・キーオン(著),須田万勢,津田篤太郎(監訳),建部陽嗣(訳).閃めく経絡. 東京:医道の日本社,2018.


ページの先頭へ

[II] 総 説

1. 中川正法.遺伝性ニューロパチー.Clinical Neuroscience 36(4):462-463,2018.
2. 中川正法.遺伝性感覚性ニューロパチー、遺伝性感覚・自律神経性ニューロパチー.Clinical Neuroscience 36(9):1071-1074,463,2018.
3. 徳田隆彦.VII.検査からみる神経疾患.「タウオパチーの血液診断:脳内に存在するアルツハイマー病理の診断」.Clinical Neuroscience.36(6):746-747,2018.
4. 徳田隆彦.TOPICS リン酸化タウ蛋白の超高感度定量システムの開発─ Alzheimer病の脳病理を診断する血液バイオマーカーとしての有用性.医学のあゆみ.266(3):233-234,2018.
5. 鈴木則宏,斎藤芳郎,関 守信,徳田隆彦.座談会.パーキンソン病のバイオマーカーへの期待.Frontiers in Parkinson Disese.11(2):63-75.(2018.6月号),2018.
6. 巨島文子.【病態に基づく摂食嚥下訓練】脳梗塞に伴う摂食嚥下障害.嚥下医学7巻1:8-14,2018.
7. 巨島文子.神経筋疾患の摂食嚥下機能評価.摂食嚥下リハビリテーションにおける機能評価.CLINICAL REHABILITATION 27 巻7号:689-694,2018.
8. 栗山長門,渡邊能行.2018.血管性認知症に関する疫学研究.京都府立医科大学雑誌京都府立医科大学医学振興会.京都.第 127 巻第7号:pp435-449.(分担執筆)
9. 栗山長門,山田真介,稲葉雅章,尾崎悦子,八木田和弘,石井好二郎,伊藤 洋,松 井大輔,小山晃英,渡邉 功,渡邊能行.2018.骨粗鬆症と不眠.ねむりとマネージメント 5.先端医学社.東京:pp22-27.(分担執筆)
10. 近藤正樹.頭頂連合野における左右差—半側空間無視,身体イメージあるいは身体図式.Brain and nerve,70(10):1059-1066,2018.
11. 永金義成.脳血栓症へのアプローチ.京都府立医科大学雑誌 127:375-382,2018.
12. 松尾雄一郎.特集 筋萎縮性側索硬化症 1筋萎縮性側索硬化症の診断.Jpn J Rehabil Med,Vol.55 No.7,534-538,2018.
13. 笠井高士,徳田隆彦.血液を用いたアルツハイマー診断法.Bios.23 巻3:7-8,2018.
14. 笠井高士,徳田隆彦.血液・髄液バイオマーカー.老年精神医学雑誌.29 巻:940-948,2018.
15. 笠井高士,徳田隆彦.成人期ダウン症候群における認知症と血液診断.日本ダウン症療育研究.in press.
16. 笠井高士,徳田隆彦.認知症とその近縁疾患に対するわが国における多面的評価方法 Up to date;日本老年精神医学会関連施設における評価方法の標準化に向けて.5.血液・髄液バイオマーカー.老年精神医学雑誌.29(9):940-948,2018.
17. 尾原知行.脳塞栓症へのアプローチ.京府医大誌.127:383-389,2018.
18. 濱中正嗣,今井啓輔.頚動脈狭窄性病変と頭蓋内動脈狭窄性病変への血管内治療.血管内治療の最近の進歩.JSA News 54 号:8-10,2018.
19. 藤井ちひろ,近藤誉之.【中枢神経系脱髄疾患の最前線—抗 MOG 抗体の関与を考える】 多発性硬化症に自己抗体の関与はあるか 免疫治療(解説/特集).Clinical Neuroscience 36 巻 11 号:1291-1295,2018.
20. 芦田真士,藤井ちひろ,水野敏樹.抗 N-methyl-D-asparate 受容体脳炎とその他の抗グルタミン酸受容体抗体関連疾患.臨床神経・アレルギー科,70 巻6号:591- 598,2018.
21. 蒔田直輝,豊田一則.血栓溶解薬.Medicina 2018 増刊号、内科臨床誌 メディチーナ Vol.55 No 4 プライマリ・ケアでおさえておきたい重要薬・頓用薬.医学書院. pp.142-145,2018.
22. 沼宗一郎.山田清文,吉村紳一.脳梗塞急性期の局所血栓回収療法の進歩.Nippon Rinsho Vol 76,No 9,2018-9.
23. 建部陽嗣,樋川正仁.経穴の解明を試みた韓国の最新研究「神経性スポット」とは. 医道の日本,77 巻1:226-228,2018.
24. 建部陽嗣,樋川正仁.論文の新検索システムで露呈する日本の鍼灸研究の大幅な遅れ. 医道の日本,77 巻2:136-138,2018.
25. 建部陽嗣,樋川正仁.論文の新検索システムが示唆する日本の鍼灸教育最大の弱点. 医道の日本,77 巻3:168-170,2018.
26. 建部陽嗣,樋川正仁.心臓と肺に浸入した鍼による新たな有害事象報告.医道の日本, 77 巻4:140-142,2018.
27. 建部陽嗣,樋川正仁.医者は鍼治療を勧めるべきか—英国医学雑誌上の賛否両論.医 道の日本,77 巻5:148-150,2018.
28. 建部陽嗣,樋川正仁.新しく解明された人体構造.世紀の大発見が鍼灸機序の謎に迫 る.医道の日本,77 巻6:140-142,2018.
29. 建部陽嗣,樋川正仁.可能性に富む頭鍼・頭皮鍼 イタリアでの fMRI 研究結果.医 道の日本,77 巻7:156-158,2018.
30. 建部陽嗣,樋川正仁.「鍼灸の理論がしっくりこない」英国鍼灸師がその理由を暴く. 医道の日本,77 巻8:138-140,2018.
31. 建部陽嗣,樋川正仁.否定され続ける不妊症への鍼灸治療.JAMA 誌掲載海外論文 の詳細.医道の日本,77 巻9:232-234,2018.
32. 建部陽嗣,樋川正仁.慢性疼痛に対する鍼治療.臨床研究結果のアップデート.医道 の日本,77 巻 10:206-208,2018.
33. 建部陽嗣,樋川正仁.鍼で体重は減るといえるのか.各論文を調査した結果が示す注 意点.医道の日本,77 巻 11:144-146,2018.
34. 建部陽嗣,樋川正仁.ラットでの基礎研究で示された血管性認知症に対する鍼治療機 序.医道の日本,77 巻 12:174-176,2018.


ページの先頭へ

[III] 原 著

1. Shiogai T, Yamamoto Y, Arima Y, Koyama M, Maejima R, Kasai T, Mizuno T.Propagation of pulse waves in the cervical arteries in relation to intracranial hemodynamics. Neurosonology. 31: 73, 2018. (abstract)
2. Fujisaki N, Suwazono S, Suehara M, Nakachi R, Kido M, Fujiwara Y, Oshiro S, Tokashiki T, Takashima H, Nakagawa M. The natural history of hereditary mo- tor and sensory neuropathy with proximal dominant involvement (HMSN-P) in 97 Japanese patients. Intractable Rare Dis Res. 7(1): 7-12, 2018.
3. Higuchi Y, Okunushi R, Hara T, Hashiguchi A, Yuan J, Yoshimura A, Mu- rayama K, Ohtake A, Ando M, Hiramatsu Y, Ishihara S, Tanabe H, Okamoto Y, Matsuura E, Ueda T, Toda T, Yamashita S, Yamada K, Koide T, Yaguchi H, Mitsui J, Ishiura H, Yoshimura J, Doi K, Morishita S, Sato K, Nakagawa M, Yamaguchi M, Tsuji S, Takashima H. Mutations in COA7 cause spinocerebellar ataxia with axonal neuropathy. Brain. 141(6): 1622-1636, 2018.
4. Muraoka Y, Nakamura A, Tanaka R, Suda K, Azuma Y, Kushimura Y, Piccolo LL, Yoshida H, Mizuta I, Tokuda T, Mizuno T, Nakagawa M, Yamaguchi M. Ge- netic screening of the genes interacting with Drosophila FIG4 identified a novel link between CMT-causing gene and long noncoding RNAs. Exp Neurol. 310: 1-13, 2018.
5. Yoshimura A, Yuan JH, Hashiguchi A, Ando M, Higuchi Y, Nakamura T, Oka- moto Y, Nakagawa M, Takashima H. Genetic profile and onset features of 1005 patients with Charcot-Marie-Tooth disease in Japan. J Neurol Neurosurg Psy- chiatry. 90(2): 195-202, 2018.
6. Tokuda N, Koga M, Ohara T, Minatoya K, Tahara Y, Higashi M, Miyazaki Y, Kajimoto K, Matsubara S, Makita N, Sakamoto Y, Iguchi Y, Mizuno T, Nagat- suka K, Toyoda K. A Japanese Case of CADASIL with a Rare Mutation in Exon 24 of the NOTCH3 Gene. Urgent Detection of Acute Type A Aortic Dissection in Hyperacute Ischemic Stroke or Transient Ischemic Attack. J Stroke Cerebrovasc Dis. 27(8): 2112-2117, 2018.
7. Akiba C, Nakajima M, Miyajima M, Ogino I, Motoi Y, Kawamura K, Adachi S, Kondo A, Sugano H, Tokuda T, Irie K, Arai H. Change of amyloid-β 1-42 toxic conformer ratio after cerebrospinal fluid diversion predicts long-term cognitive outcome in patients with idiopathic normal pressure hydrocephalus. J Alzheim- ers Dis. 63(3): 989-1002, 2018.
8. Komatsu J, Samuraki M, Nakajima K, Arai H, Arai H, Arai T, Asada T, Fujishi- ro H, Hanyu H, Iizuka O, Iseki E, Kashihara K, Kosaka K, Maruno H, Mizukami K, Mizuno Y, Mori E, Nakamura H, Nakano S, Nakashima K, Nishio Y, Orimo S, Takahashi A, Taki J, Tokuda T, Urakami K, Utsumi K, Wada K, Washimi Y, Yamashina S, Yamasaki J, Yoshita M, Yamada M. 123I-MIBG myocardial scin- tigraphy for the diagnosis of DLB: a multicentre 3-year follow-up study. J Neurol Neurosurg Psychiatry. 89(11): 1167-1173, 2018.
9. Takahashi R, Ishii K, Tokuda T, Nakajima M, Okada T, SINPHONI-2 Investigators. Regional dissociation between the cerebral blood flow and gray matter density alterations in idiopathic normal pressure hydrocephalous: results from SINPHONI-2 study. Neuroradiology, 2018 [Epub ahead of print].
10. Nakajima M, Miyajima M, Ogino I, Akiba C, Kawamura K, Kamohara C, Fusegi K, Harada Y, Hara T, Sugano H, Tange Y, Karagiozov K, Kasuga K, Ikeuchi T, Tokuda T, Arai H. Preoperative Phosphorylated Tau Concentration in the Cere- brospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus. J Alzheimers Dis. 66(1): 319-331, 2018.
11. Ebihara Y, Mochizuki H, Ishii N, Mizuta I, Shiomi K, Mizuno T, Nakazato M. A Japanese Case of CADASIL with a Rare Mutation in Exon 24 of the NOTCH3 Gene. Intern Med. 57(20): 3011-3014, 2018.
12. Yeung WTE, Mizuta I, Watanabe-Hosomi A, Yokote A, Koizumi T, Mukai M, Kinoshita M, Ohara T, Mizuno T. RNF213-related susceptibility of Japanese CADASIL patients to intracranial arterial stenosis. J Hum Genet. 63(5): 687-690, 2018.
13. Tachiyama K, Shiga Y, Shimoe Y, Mizuta I, Mizuno T, Kuriyama M. CADASIL with cysteine-sparing NOTCH3 mutation manifesting as dissociated progression between cognitive impairment and brain image findings in 3 years: A case report. Rinsho Shinkeigaku. 25; 58(4): 235-240, 2018.
14. Konno T, Yoshida K, Mizuta I, Mizuno T, Kawarai T, Tada M, Nozaki H, Ikeda SI, Onodera O, Wszolek ZK, Ikeuchi T. Diagnostic criteria for adult-onset leuko- encephalopathy with axonal spheroids and pigmented glia due to CSF1R muta- tion. Eur J Neurol. 25(1): 142-147, 2018.
15. Kuriyama N, Ozaki E, Mizuno T, Ihara M, Mizuno S, Koyama T, Matsui D, Watanabe I, Akazawa K, Takeda K, Takada A, Inaba M, Yamada S, Motoyama K, Takeshita W, Iwai K, Hashiguchi K, Kobayashi D, Kondo M, Tamura A, Yama- da K, Nakagawa M, Watanabe Y. Association between α-Klotho and Deep White Matter Lesions in the Brain: A Pilot Case Control Study Using Brain MRI. J Al- zheimers Dis. 61(1): 145-155, 2018.
16. Kobayashi D, Kuriyama N, Hirano K, Takahashi O, Noto H. 2018. Malignancy incidences by glycemic control among diabetic patients. Endocr Connect. [Epub ahead of print].
17. Nakajima M, Miyajima M, Ogino I, Akiba C, Kawamura K, Kurosawa M, Kuri- yama N, Watanabe Y, Fukushima W, Mori E, Kato T, Sugano H, Karagiozov K, Arai H. 2018. Shunt Intervention for Possible Idiopathic Normal Pressure Hy- drocephalus Improves Patient Outcomes: A Nationwide Hospital-Based Survey in Japan. Front Neurol. 9: 421, 2018.
18. Fujii R, Hishida A, Nakatochi M, Furusyo N, Murata M, Tanaka K, Shimanoe C, Suzuki S, Watanabe M, Kuriyama N, Koyama T, Takezaki T, Shimoshikiryo I, Arisawa K, Katsuura-Kamano S, Takashima N, Turin TC, Kuriki K, Endoh K, Mikami H, Nakamura Y, Oze I, Ito H, Kubo M, Momozawa Y, Kondo T, Naito M, Wakai K. 2018. Association of genetic risk score and chronic kidney disease in a Japanese population. Nephrology. [Epub ahead of print]
19. Hara M, Hachiya T, Sutoh Y, Matsuo K, Nishida Y, Shimanoe C, Tanaka K, Shimizu A, Ohnaka K, Kawaguchi T, Oze I, Matsuda F, Ito H, Kawai S, Hishida A, Okada R, Sasakabe T, Hirata A, Ibusuki R, Nindita Y, Furusyo N, Ikezaki H, Kuriyama N, Ozaki E, Mikami H, Nakamura Y, Suzuki S, Hosono A, Katsuura- Kamano S, Arisawa K, Kuriki K, Endoh K, Takashima N, Kadota A, Nakatochi M, Momozawa Y, Kubo M, Naito M, Wakai K. 2018. Genome-wide Association Study of Leisure-Time Exercise Behavior in JapaneseAdults. Med Sci Sports Ex- erc. [Epub ahead of print]
20. Nakamura M, Inaba M, Yamada S, Ozaki E, Maruo S, Okuno S, Imanishi Y, Kuriyama N, Watanabe Y, Emoto M, Motoyama K. 2018. Association of De- creased Handgrip Strength with Reduced Cortical Thickness in Japanese Female Patients with Type 2 Diabetes Mellitus. Sci Rep. 17; 8: 10767, 2018.
21. Kobayashi D, Suyama Y, Osugi Y, Arioka H, Takahashi O, Kuriyama N. 2018. Incidence of cardiovascular events in polymyalgia rheumatica and giant cell arte- ritis amongst an Asian population: Propensity score matched cohort study. Int J Rheum Dis. 21: 1314-1321, 2018.
22. Inenaga C, Hokamura K, Nakano K, Nomura R, Naka S, Ohashi T, Ooshima T, Kuriyama N, Hamasaki T, Wada K, Umemura K, Tanaka T. World Neurosurg. 113: e77-e81, 2018.
23. Miyamoto K, Fujihara K, Kira J, Kuriyama N, Matsui M, Tamakoshi A, Kusu- noki S. 2018. A nationwide epidemiological study of neuromyelitis optica in Ja- pan. J Neurol Neurosurg Psychiatry. 89: 667-668, 2018.
24. Kobayashi D, Kuriyama N, Osugi Y, Arioka H, Takahashi O. Longitudinal rela- tionships between cardiovascular events, risk factors, and time-dependent sleep duration. Cardiol J. 25: 229-235, 2018.
25. Kuriyama N, Ozaki E, Mizuno T, Ihara M, Mizuno S, Koyama T, Matsui D, Watanabe I, Akazawa K, Takeda K, Takada A, Inaba M, Yamada S, Motoyama K, Takeshita W, Iwai K, Hashiguchi K, Kobayashi D, Kondo M, Tamura A, Ya- mada K, Nakagawa M, Watanabe Y. 2018. Association between α-Klotho and Deep White Matter Lesions in the Brain: A Pilot Case Control Study Using Brain MRI. J Alzheimers Dis. 61: 145-155, 2018.
26. Nakagawa-Senda H, Hachiya T, Shimizu A, Hosono S, Oze I, Watanabe M, Matsuo K, Ito H, Hara M, Nishida Y, Endoh K, Kuriki K, Katsuura-Kamano S, Arisawa K, Nindita Y, Ibusuki R, Suzuki S, Hosono A, Mikami H, Nakamura Y, Takashima N, Nakamura Y, Kuriyama N, Ozaki E, Furusyo N, Ikezaki H, Nakatochi M, Sasakabe T, Kawai S, Okada R, Hishida A, Naito M, Wakai K, Momozawa Y, Kubo M, Tanaka H., 2018. A genome-wide association study in the Japanese population identifies the 12q24 locus for habitual coffee consumption: The J-MICC Study. Sci Rep. 8: 1493, 2018.
27. Ozaki E, Yamada S, Kuriyama N, Matsui D, Watanabe I, Koyama T, Imanishi Y, Inaba M, Watanabe Y. 2018. Association of BAP with urinary albumin excretion in postmenopausal, but not premenopausal, non-CKD Japanese women. Sci Rep. 8: 82, 2018.
28. Nakase T, Moroi J, Ishikawa T. Anti-inflammatory and antiplatelet effects of non-vitamin K antagonist oral anticoagulants in acute phase of ischemic stroke patients. Clin Transl Med. 12; 7(1): 2, 2018.
29. Nakase T, Moroi J, Ishikawa T. Outcome of Secondary Stroke Prevention in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants. J Stroke Cere- brovasc Dis. 27; (5): 1174-1177, 2018.
30. Kawano T, Miyashita K, Takeuchi M, Nagakane Y, Yamamoto Y, Kamiyama K, Manabe Y, Todo K, Metoki N, Akaiwa Y, Toyoda K, Nagatsuka K. Blood biomarkers associated with neurological deterioration in patients with acute penetrating artery territory infarction: A multicenter prospective observational study. Int J Stroke. 13: 207-216, 2018.
31. Tokunaga K, Yamagami H, Koga M, Todo K, Kimura K, Itabashi R, Terasaki T, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Kameda T, Nagakane Y, Hasegawa Y, Shibuya S, Ito Y, Matsuoka H, Takamatsu K, Nishi- yama K, Kario K, Yagita Y, Kitazono T, Kinoshita N, Takasugi J, Okata T, Yo- shimura S, Sato S, Arihiro S, Toyoda K; SAMURAI Study Investigators. Associations between Pre-Admission Risk Scores and Two-Year Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients with Non-Valvular Atrial Fibrillation. Cerebrovasc Dis. 45: 170-179, 2018.
32. Yoshimura S, Koga M, Sato S, Todo K, Yamagami H, Kumamoto M, Itabashi R, Terasaki T, Kimura K, Yagita Y, Shiokawa Y, Kamiyama K, Okuda S, Okada Y, Takizawa S, Hasegawa Y, Kameda T, Shibuya S, Nagakane Y, Ito Y, Matsuoka H, Takamatsu K, Nishiyama K, Fujita K, Kamimura T, Ando D, Ide T, Yoshimoto T, Shiozawa M, Matsubara S, Yamaguchi Y, Kinoshita N, Matsuki T, Takasugi J, Tokunaga K, Higashida K, Homma K, Kario K, Arihiro S, Toyoda K; SAMURAI Study Investigators. Two-Year Outcomes of Anticoagulation for Acute Ischemic Stroke With Nonvalvular Atrial Fibrillation - SAMURAI-NVAF Study. Circ J. 82: 1935-1942, 2018.
33. Ohshima Y, Taguchi K, Mizuta I, Tanaka M, Tomiyama T, Kametani F, Yabe- Nishimura C, Mizuno T, Tokuda T. Mutations in the β-amyloid precursor pro- tein in familial Alzheimer’s disease increase Aβ oligomer production in cellular models. Heliyon. 2018 4(1): e00511, 2018.
34. Ohshima Y, Iwata K, Ibi M, Matsumoto M, Katsuyama M, Yabe-Nishimura C. Nicotine and methyl vinyl ketone, major components of cigarette smoke extracts, increase protective amyloid-β peptides in cells harboring amyloid-β precursor protein. J. Toxicol. Sci. Vol. 43 (4), 257-266, 2018.
35. Ishihara T, Sato S, Uehara T, Ohara T, Hayakawa M, Kimura K, Okada Y, Hasegawa Y, Tanahashi N, Suzuki A, Nakagawara J, Arii K, Nagahiro S, Ogasawara K, Uchiyama S, Matsumoto M, Iihara K, Toyoda K, Minematsu K; PROMISE-TIA Study Investigators. Significance of nonfocal symptoms in patients with transient ischemic attack: The PROMISE-TIA Study. Stroke. 49: 1893-1898, 2018.
36. Uehara T, Ohara T, Minematsu K, Nagatsuka K, Toyoda K. Predictors of stroke events in patients with TIA attributable to intracranial stenotic lesions. Intern Med. 57: 295-300, 2018.
37. Koga M, Iguchi Y, Ohara T, Tahara Y, Fukuda T, Noguchi T, Matsuda H, Mi- natoya K, Nagatsuka K, Toyoda K. Acute ischemic stroke as a complication of Stanford type A acute aortic dissection: a review and proposed clinical recom- mendations for urgent diagnosis. Gen Thorac Cardiovasc Surg. 66: 439-445, 2018.
38. Matsubara S, Koga M, Ohara T, Iguchi Y, Minatoya K, Tahara Y, Fukuda T, Miyazaki Y, Kajimoto K, Sakamoto Y, Makita N, Tokuda N, Nagatsuka K, Ando Y, Toyoda K. Cerebrovascular imaging of cerebral ischemia in acute type A aortic dissection. J Neurol Sci. 388: 23-27, 2018.
39. Kitamura S, Shimada H, Niwa F, Endo H, Shinotoh H, Takahata K, Kubota M, Takado Y, Hirano S, Kimura Y, Zhang MR, Kuwabara S, Suhara T, Higuchi M. Tau-induced focal neurotoxicity and network disruption related to apathy in Al- zheimer’s disease. J Neurol Neurosurg Psychiatry 89(11): 1208-1214, 2018.
40. Shinotoh H, Shimada H, Kokubo Y, Tagai K, Niwa F, Kitamura S, Endo H, Ono M, Kimura Y, Hirano S, Mimuro M, Ichise M, Sahara N, Zhang MR, Suhara T, Higuchi M. Tau imaging detects distinctive distribution of tau pathology in ALS/PDC on the Kii Peninsula. Neurology. 92(2): e136-e147, 2018.
41. Fujii C, Itoh K, Saito K, Satoh Y, Makino M, Nakagawa M, Yamaguchi K, Fu- shiki S, Mizuno T. Persistent microscopic active inflammatory lesions in the central nervous system of a patient with neuromyelitis optica treated with oral prednisolone for more than 40 years. eNeurologicalSci. 23; 11: 17-19, 2018.
42. Okada Y, Ochi H, Fujii C, Hashi Y, Hamatani M, Ashida S, Kawamura K, Kusa- ka H, Matsumoto S, Nakagawa M, Mizuno T, Takahashi R, Kondo T. Signaling Via toll-like receptor 4 and CD40 in B cells plays a regulatory role in the patho- genesis of multiple sclerosis through interleukin-10 production. J Autoimmun. 88: 103-113, 2018.
43. Garg N, Park SB, Howells J, Noto Y, Vucic S, Yiannikas C, Tomlinson SE, Huynh W, Simon NG, Mathey EK, Spies J, Pollard JD, Krishnan AV, Kiernan MC. Anti-MAGneuropathy: Role of IgM antibodies, the paranodal junction and juxtaparanodal potassium channels. Clin Neurophysiol. 129(10): 2162-2169, 2018.
44. Noto Y, Garg N, Li T, Timmins HC, Park SB, Shibuya K, Shahrizaila N, Huynh W, Matamala JM, Dharmadasa T, Yiannikas C, Vucic S, Kiernan MC. Compari- son of cross-sectional areas and distal-proximal nerve ratios in amyotrophic lat- eral sclerosis. Muscle Nerve. 58(6): 777-783, 2018.
45. Noto Y, Simon NG, Selby A, Garg N, Shibuya K, Shahrizaila N, Huynh W, Matamala JM, Dharmadasa T, Park SB, Vucic S, Kiernan MC. Ectopic impulse- generation in peripheral nerve hyperexcitability syndromes and amyotrophic lateral sclerosis. Clin Neurophysiol. 129(5): 974-980, 2018.
46. Garg N, Park SB, Yiannikas C, Vucic S, Howells J, Noto Y, Mathey EK, Pollard JD, Kiernan MC. Neurofascin-155 IGG4 Neuropathy: Pathophysiological In- sights, Spectrum of Clinical Severity and Response To treatment. Muscle Nerve. 57(5): 848-851, 2018.
47. Kawarai T, Miyamoto R, Nakagawa E, Koichihara R, Sakamoto T, Mure H, Morigaki R, Koizumi H, Oki R, Montecchiani C, Caltagirone C, Orlacchio A, Hattori A, Mashimo H, Izumi Y, Mezaki T, Kumada S, Taniguchi M, Saitoh S, Goto S, Kaji R. Phenotype variability and allelic heterogeneity in KMT2B-Asso- ciated disease. Parkinsonism Relat Disord. 52: 55-61, 2018.
48. Tanaka A, Hata J, Akamatsu N, Mukai N, Hirakawa Y, Yoshida D, Kishimoto H, Ohara T, Mizuno T, Tsuji S, Kitazono T, Ninomiya T. Prevalence of Adult Epi- lepsy in a General Japanese Population: the Hisayama Study. Epilepsia Open. 24, 2018.
49. Yokoya S, Tamura A, Hino A, Bamba M, Kato T, Takezawa H, Goto Y, Oka H, Fujii A, Hashimoto Y. Unusual Clinical Sequelae of Kawasaki Disease-Symptom- atic Extracranial Internal Carotid Stenosis in Young Adult. World Neurosur- gery. 117: 162-164, 2018.
50. Azuma Y, Tokuda T, Kushimura Y, Yamamoto I, Mizuta I, Mizuno T, Nakaga- wa M, Ueyama M, Nagai Y, Iwasaki Y, Yoshida M, Pan D, Yoshida H, Yamagu- chi M. Hippo, Drosophila MST, is a novel modifier of motor neuron degeneration induced by knockdown of Caz, Drosophila FUS. Exp Cell Res. 371: 311-321, 2018.
51. Yamamoto I, Azuma Y, Kushimura Y, Yoshida H, Mizuta I, Mizuno T, Ueyama M, Nagai Y, Tokuda T, Yamaguchi M. NPM-hMLF1 fusion protein suppresses defects of a Drosophila FTLD model expressing the human FUS gene. Sci Rep. 8: 11291, 2018.
52. Muraoka Y, Nakamura A, Tanaka R, Suda K, Azuma Y, Kushimura Y, Lo Pic- colo L, Yoshida H, Mizuta I, Tokuda T, Mizuno T, Nakagawa M, Yamaguchi M. Genetic screening of the genes interacting with Drosophila FIG4 identified a novel link between CMT-causing gene and long noncoding RNAs. Exp Neurol. 310: 1-13, 2018.
53. Suda K, Ueoka I, Azuma Y, Muraoka Y, Yoshida H, Yamaguchi M. Novel Dro- sophila model for mitochondrial diseases by targeting of a solute carrier protein SLC25A46. Brain Res. 1689: 30-44, 2018.
54. Wakisaka K. T, Tanaka R, Hirashima T, Muraoka Y, Azuma Y, Yoshida H, Tokuda T, Asada S, Suda K, Ichiyanagi K, Ohno S, Itoh M, Yamaguchi M. Novel roles of Drosophila FUS and Aub responsible for piRNA biogenesis in neuronal disorders. Brain Research. pii: S0006-8993(18)30646-2, 2018.
55. Uemura H, Shimozato R, Matsunaga N, Hayashi M, Takezawa H, Hidaka Y, Iijima A. Aneurysmal Coil Embolization Using Gadolinium in a Patient with Allergy to Iodinated Contrast Medium: Case Report. Journal on Neuroendovascular Therapy. 12: 393-397, 2018.
56. Shimozato R, Hayashi M, Niimura M, Kugasawa K, Uemura H, Hidaka Y, Takezawa H, Hamanaka M, Imai K, Iijima A. Two Patients with Cerebral In- garction Who Underwent Endovascular Treatment for Internal Carotid Artery Dissection Related to an Elongated Styloid Process. Journal on Neuroendovascu- lar Therapy. 12: 355-361, 2018.
57. Saito K, Fukazawa R, Ogura S, Kasai T, Mizuno T. A case of extensive epidural abscess concomitant with intracranial involvement due to Staphylococcus aureus successfully treated with ceftriaxone in combination with linezolid and rifampin. eNeurologicalSci. 14: 1-3, 2018.
58. Saito K, Shigetomi E, Yasuda R, Sato R, Nakano M, Tashiro K, Tanaka KF, Ike- naka K, Mikoshiba K, Mizuta I, Yoshida T, Nakagawa M, Mizuno T, Koizumi S. Aberrant astrocyte Ca2+ signals “AxCa signals” exacerbate pathological altera- tions in an Alexander disease model. Glia. 66(5): 1053-1067, 2018.
59. Fujinami J, Ohara T, Kitani-Morii F, Tomii Y, Makita N, Yamada T, Kasai T, Nagakane Y, Nakagawa M, Mizuno T. Cancer-Associated Hypercoagulation In- creases the Risk of Early Recurrent Stroke in Patients with Active Cancer. Cere- brovasc Dis. 46(1-2): 46-51, 2018.
60. Mukai M, Mizuta I, Ueda A, Nakashima D, Kushimura Y, Noto Y, Ohara T, Itoh K, Ando Y, Mizuno T. A Japanese CADASIL patient with homozygous NOTCH3 p. Arg544Cys mutation confirmed pathologically. J Neurol Sci. 394: 38-40, 2018.
61. Nakazato T, Tsuji Y, Kanai K, Noto YI, Hoshino Y, Yamashiro K, Yokoyama K, Nishioka K, Shimo Y, Watanabe O, Mizuno T, Hattori N. Isaacs syndrome: A slow potassium channelopathy caused by autoantibodies? Clin Neurophysiol. 129(5): 956-958, 2018.
62. Yuan JH, Hashiguchi A, Okamoto Y, Yoshimura A, Ando M, Shiomi K, Saito K, Takahashi M, Ichinose K, Ohmichi T, Ichikawa K, Tadashi A, Takigawa H, Shibayama H, Takashima H. Clinical and mutational spectrum of Japanese pa- tients with recessive variants in SH3TC2. J Hum Genet. 63(3): 281-287, 2018.
63. Ohmichi T, Kondo M, Itsukage M, Koizumi H, Matsushima S, Kuriyama N, Ishii K, Mori E, Yamada K, Mizuno T, Tokuda T. Usefulness of the convexity appar- ent hyperperfusion (CAPPAH) Sign in 123I-iodoamphetamine brain perfusion SPECT for the diagnosis of idiopathic normal pressure hydrocephalus. J Neuro- surg. 16: 1-8, 2018.
64. Ohmichi T, Kasai T, Kosaka T, Shikata K, Tatebe H, Ishii R, Shinomoto M, Mizuno T, Tokuda T. Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson’s dis- ease. PLoS One. 13(7): e0201260, 2018.
65. Ohmichi T, Mitsuhashi M, Tatebe H, Kasai T, Ali El-Agnaf OM, Tokuda T. Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose Parkinson’s and related diseases. Parkinsonism Relat Disord. pii: S1353- 8020(18) 30518-2, 2018.
66. Kushimura Y, Azuma Y, Mizuta I, Muraoka Y, Kyotani A, Yoshida H, Tokuda T, Mizuno T, Yamaguchi M. Loss-of-function mutation in Hippo suppressed enlargement of lysosomes and neurodegeneration caused by dFIG4 knockdown. Neuro Report 29: 856-892, 2018.
67. Kushimura Y, Tokuda T, Azuma Y, Yamamoto I, Mizuta I, Mizuno T, Nakaga- wa M, Ueyama M, Nagai Y, Yoshida H, Yamaguchi M. Overexpression of ter94, Drosophila VCP, improves motor neuron degeneration induced by knockdown of TBPH, Drosophila TDP-43. Am J Neurodegener Dis. 7(1): 11-31, 2018.
68. Tokuda N, Koga M, Ohara T, Minatoya K, Tahara Y, Higashi M, Miyazaki Y, Kajimoto K, Matsubara S, Makita N, Sakamoto Y, Iguchi Y, Mizuno T, Na- gatsuka K, Toyoda K. Urgent Detection of Acute Type A Aortic Dissection in Hyperacute Ischemic Stroke or Transient Ischemic Attack. J Stroke Cerebrovasc Dis. 27: 2112-2117, 2018.
69. Matsuura J, Fujii A, Mizuta I, Norose K, Mizuno T. Cerebral Toxoplasmosis Diagnosed by Nested-Polymerase Chain Reaction in a Patient with Rheumatoid Arthritis. Intern Med. 57: 1463-1468, 2018.
70. Takewaki D, Lin Y, Sato W, Ono H, Nakamura M, Araki M, Okamoto T, Taka- hashi Y, Kimura Y, Ota M, Sato N, Yamamura T. Normal brain imaging accom- panies neuroimmunologically justified, autoimmune encephalomyelitis. Neurol- ogy neuroimmunology & neuroinflammation 5, e456, 2018.
71. Shinomoto M, Kasai T, Tatebe H, Kondo M, Ohmichi T, Morimoto M, Chiyono- bu T, Terada N, Allsop D, Yokota I, Mizuno T, Tokuda T. Plasma neurofilament light chain: a potentiall prognostic biomarker of dementia in adult Down syn- drome patients. PLoS One. (in press)
72. Nakashima D, Noto YI, Tsuji Y, Fujii C, Tanaka A, Ohara T, Nakagawa M, Mizuno T. A case of acute-onset multifocal motor neuropathy after Mycoplasma infection. Muscle Nerve. Aug; 58(2): E18-E20, 2018.
73. Takahashi H, Kimura T, Yuki N, Yoshioka A. An adult case of recurrent Guil- lain-Barre syndrome with anti-galactocerebroside antibodies. Intern Med. 57: 409-412, 2018.
74. Takahashi H, Ueshima T, Goto D, Kimura T, Yuki N, Inoue Y, Yoshioka A. Acute tetrapareis with respiratory failure after steroid administration in a pa- tient with a dural arteriovenous fistula at the craniocervical junction. Intern Med. 57: 591-594, 2018.
75. Takahashi H, Kimura T, Yuki N, Yoshioka A. Stroke-like migraine attacks after radiation therapy (SMART) syndrome followed by cerebral infarction. Intern Med. 57: 1921-1924, 2018.
76. Shimizu H, Nishino I, Ueda T, Kohara N, Nishioka H. Anti-mitochondrial anti- body-associated myositis with eosinophilia and dropped head. eNeurologicalSci. 11: 15-16, 2018.
77. Ogura S, Narumiya H, Iiduka R, Nagakane Y. Late recovery from unconscious- ness in a patient with severe posterior reversible encephalopathy syndrome. Clin Case Rep. 30; 6(9): 1825-1828, 2018.
78. Taki M, Nakamura T, Matsuura H, Hasegawa T, Sakaguchi H, Morita K, Ishii R, Mizuta I, Kasai T, Mizuno T, Hirano S. Cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS). Auris Nasus Larynx. 45(4): 866-870, 2018.
ページの先頭へ

ページの先頭へ